Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;21(9):3689-3691.
doi: 10.1111/jocd.15208. Epub 2022 Jul 19.

Mucocutaneous lichenoid eruptions following COVID-19 vaccination: A keen observation

Aakanksha Arora  1 , Alpana Mohta  1 , Bhikam Chand Ghiya  1 , Prasoon Soni  1 , Vishnu Kumar Jangir  1 , Rajesh Datt Mehta  1
Affiliations

Mucocutaneous lichenoid eruptions following COVID-19 vaccination: A keen observation

Aakanksha Arora et al. J Cosmet Dermatol. 2022 Sep.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) Eruptive lichen planus 20 days following vaccination; (B) linear LP 10 days after vaccination; (C) vulvovaginal LP 1 month following vaccination; (D) reticular oral LP 14 days following vaccination
See this image and copyright information in PMC

References

    1. Farinazzo E, Ponis G, Zelin E, et al. Cutaneous adverse reactions after m‐RNA COVID‐19 vaccine: early reports from Northeast Italy. J Eur Acad Dermatol Venereol. 2021;35:e548‐e551. - PMC - PubMed
    1. Lai YC, Yew YW. Lichen planus and lichenoid drug eruption after vaccination. Cutis. 2017;100(6):E6‐E20. - PubMed
    1. McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID‐19 vaccination: a registry‐based study of 414 cases. J Am Acad Dermatol. 2021;85:46‐55. - PMC - PubMed
    1. Hiltun I, Sarriugarte J, Martínez‐de‐Espronceda I, et al. Lichen planus arising after COVID‐19 vaccination. J Eur Acad Dermatol Venereol. 2021;35:e414‐e415. - PMC - PubMed
    1. Onn PY, Chang CL. Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer‐BioNTech mRNA COVID‐19 vaccine administration. Respirol Case Rep. 2021;9(11):e0860. - PMC - PubMed

MeSH terms

Substances